*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
My team has been following clinical-stage biotech company LCTX for the past few months. LCTX pipeline looks very promising. We believe that current price levels are undermining the companies potential. We entered LCTX on 5/14/21 at $2.23 per share and have been holding ever since. Following its correction from its 52-week high of $3.13 LCTX now sits at $2.80 per share.
My team averaged up on our LCTX position this morning at $2.70 per share and intend to take profit at $4.20.
ORIGINAL ENTRY: $2.23 AVERAGING UP AT: $2.70 TAKE PROFIT: $4.20 STOP PROFIT LOSS: $2.50
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.